Insider Buy/Sell Details for the Biotechnology Industry — Last 7 Days
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (149)
Revolution Medicines, Inc. (RVMD)
Horn Margaret A — Chief Operating Officer
Shares
76
Price
$195.01
Total Value
$14.82K
Shares Held After
154,571
% of Holdings
0.0%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — SVP&General Counsel
Shares
3,314
Price
$199.30
Total Value
$660.49K
Shares Held After
52,541
% of Holdings
5.9%
Revolution Medicines, Inc. (RVMD)
Cislini Jeff — SVP&General Counsel
Shares
52
Price
$195.01
Total Value
$10.14K
Shares Held After
55,855
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
13,775
Price
$199.30
Total Value
$2.75M
Shares Held After
253,342
% of Holdings
5.2%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
3,992
Price
$199.30
Total Value
$795.62K
Shares Held After
119,216
% of Holdings
3.2%
Revolution Medicines, Inc. (RVMD)
GOLDSMITH MARK A — Director
Shares
213
Price
$195.01
Total Value
$41.54K
Shares Held After
267,117
% of Holdings
0.1%
Revolution Medicines, Inc. (RVMD)
Anders Jack — Chief Financial Officer
Shares
61
Price
$195.00
Total Value
$11.89K
Shares Held After
123,208
% of Holdings
0.0%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
7,006
Price
$67.35
Total Value
$471.85K
Shares Held After
1,306,594
% of Holdings
0.5%
PTC THERAPEUTICS, INC. (PTCT)
SCHMERTZLER MICHAEL — Director
Shares
2,994
Price
$66.58
Total Value
$199.34K
Shares Held After
1,313,600
% of Holdings
0.2%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
1,800
Price
$43.01
Total Value
$77.43K
Shares Held After
13,115
% of Holdings
12.1%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
12,394
Price
$16.33
Total Value
$202.44K
Shares Held After
39,900
% of Holdings
23.7%
MapLight Therapeutics, Inc. (MPLT)
Hanson Kristopher — General Counsel
Shares
16,509
Price
$11.67
Total Value
$192.66K
Shares Held After
137,044
% of Holdings
10.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Bispham Barbara Harlin — General Counsel and Corporate Secretary.
Shares
620
Price
$17.90
Total Value
$11.10K
Shares Held After
18,710
% of Holdings
3.2%
CRESCENT BIOPHARMA, INC. (CBIO)
Scalzo Richard William — Chief Financial Officer
Shares
568
Price
$17.90
Total Value
$10.17K
Shares Held After
19,730
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Im Ellie Eunkyung — Chief Medical Officer
Shares
623
Price
$17.90
Total Value
$11.15K
Shares Held After
21,446
% of Holdings
2.8%
CRESCENT BIOPHARMA, INC. (CBIO)
Pinkas Jan — Chief Scientific Officer
Shares
658
Price
$17.90
Total Value
$11.78K
Shares Held After
21,581
% of Holdings
3.0%
CRESCENT BIOPHARMA, INC. (CBIO)
Brumm Joshua T — Director
Shares
1,610
Price
$17.90
Total Value
$28.82K
Shares Held After
279,602
% of Holdings
0.6%
CRESCENT BIOPHARMA, INC. (CBIO)
McNeill Jonathan — President and COO
Shares
731
Price
$17.90
Total Value
$13.08K
Shares Held After
138,427
% of Holdings
0.5%
CRESCENT BIOPHARMA, INC. (CBIO)
Lynch Ryan — Treasurer, Senior Vice President of Finance and Chief Accounting Officer.
Shares
240
Price
$17.90
Total Value
$4.30K
Shares Held After
13,631
% of Holdings
1.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$505.20
Total Value
$60.62K
Shares Held After
324,443
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,182
Price
$504.17
Total Value
$595.93K
Shares Held After
324,563
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,538
Price
$503.53
Total Value
$774.43K
Shares Held After
325,745
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,160
Price
$502.44
Total Value
$1.09M
Shares Held After
327,283
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
708
Price
$501.52
Total Value
$355.08K
Shares Held After
329,443
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
492
Price
$500.19
Total Value
$246.10K
Shares Held After
330,151
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,220
Price
$499.15
Total Value
$608.97K
Shares Held After
330,643
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,080
Price
$498.45
Total Value
$1.04M
Shares Held After
331,863
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
4,000
Price
$108.99
Total Value
$435.96K
Shares Held After
58,839
% of Holdings
6.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
8,896
Price
$108.04
Total Value
$961.12K
Shares Held After
62,839
% of Holdings
12.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,000
Price
$106.83
Total Value
$320.48K
Shares Held After
71,735
% of Holdings
4.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Posard Matthew L. — Director
Shares
3,100
Price
$106.13
Total Value
$329.01K
Shares Held After
74,735
% of Holdings
4.0%
TENAX THERAPEUTICS, INC. (TENX)
Doogan Declan — Director
Shares
53,000
Price
$1.92
Total Value
$101.76K
Shares Held After
55,274
% of Holdings
95.9%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
96,125
Price
$63.64
Total Value
$6.12M
Shares Held After
432,886
% of Holdings
18.2%
Travere Therapeutics, Inc. (TVTX)
Dube Eric M — Director
Shares
99,716
Price
$63.26
Total Value
$6.31M
Shares Held After
529,011
% of Holdings
15.9%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
47,746
Price
$63.61
Total Value
$3.04M
Shares Held After
98,197
% of Holdings
32.7%
Travere Therapeutics, Inc. (TVTX)
ROTE WILLIAM E. — Chief Research Officer
Shares
65,104
Price
$63.12
Total Value
$4.11M
Shares Held After
145,943
% of Holdings
30.8%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
79,113
Price
$63.65
Total Value
$5.04M
Shares Held After
117,066
% of Holdings
40.3%
Travere Therapeutics, Inc. (TVTX)
Heerma Peter — EVP, CHIEF COMMERCIAL OFFICER
Shares
93,604
Price
$63.25
Total Value
$5.92M
Shares Held After
196,179
% of Holdings
32.3%
Inhibrx Biosciences, Inc. (INBX)
Kayyem Jon Faiz — Director
Shares
5,000
Price
$100.00
Total Value
$500.00K
Shares Held After
429,360
% of Holdings
1.2%
Upstream Bio, Inc. (UPB)
Deykin Aaron — Chief Medical Officer
Shares
895
Price
$5.49
Total Value
$4.91K
Shares Held After
32,302
% of Holdings
2.7%
Upstream Bio, Inc. (UPB)
Houghton Adam — Chief Business Officer
Shares
700
Price
$5.49
Total Value
$3.84K
Shares Held After
22,901
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
Sutherland Everett Rand — Director
Shares
2,095
Price
$5.49
Total Value
$11.50K
Shares Held After
68,717
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
GRAY MICHAEL — CFO and COO
Shares
853
Price
$5.49
Total Value
$4.68K
Shares Held After
27,942
% of Holdings
3.0%
Upstream Bio, Inc. (UPB)
Ambrose Allison — General Counsel
Shares
485
Price
$5.49
Total Value
$2.66K
Shares Held After
15,563
% of Holdings
3.0%
AIM ImmunoTech Inc. (AIM)
Equels Thomas K — Director
Shares
11,000
Price
$0.21
Total Value
$2.31K
Shares Held After
102,822
% of Holdings
10.7%
Adagene Inc. (ADAG)
Luo Peter — Director
Shares
20,290
Price
$3.15
Total Value
$63.98K
Shares Held After
88,535
% of Holdings
22.9%
InMed Pharmaceuticals Inc. (INM)
ADAR1 Capital Management, LLC — 10% Owner
Shares
8,340
Price
$1.29
Total Value
$10.75K
Shares Held After
892,101
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
15,000
Price
$96.09
Total Value
$1.44M
Shares Held After
553,209
% of Holdings
2.6%
Showing 51–100 of 149 transactions (page 2 of 3)